South Korea vs Lithuania: Enforcing contracts: Court structure and proceedings (0-5)
Enforcing contracts: Court structure and proceedings (0-5) over time
- South Korea
- Lithuania
How they compare
South Korea currently reports 3.5 DB17-20 methodology against 3.5 DB17-20 methodology in Lithuania, a difference of 0 DB17-20 methodology.
Across all 5 years both countries report, Lithuania has been ahead every year.
South Korea ranks 67th and Lithuania ranks 67th of 188 countries.
Frequently asked questions
- Which has higher enforcing contracts: court structure and proceedings (0-5), South Korea or Lithuania?
- South Korea, at 3.5 DB17-20 methodology against 3.5 DB17-20 methodology in Lithuania as of 2019.
- What is the difference in enforcing contracts: court structure and proceedings (0-5) between South Korea and Lithuania?
- 0 DB17-20 methodology, with South Korea ahead.
- How many years of comparable data are there for South Korea and Lithuania?
- 5 years are reported by both, from 2015 to 2019.
- How do South Korea and Lithuania rank globally for enforcing contracts: court structure and proceedings (0-5)?
- South Korea ranks 67th and Lithuania ranks 67th of 188 countries.
- Where does this data come from?
- The World Bank, published as Enforcing contracts: Court structure and proceedings (0-5) (DB17-20 methodology). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The court structure and proceedings evaluates five aspects of the court system: (i) whether a specialized commercial court, division or section is available; (ii) whether a small claims court and/or simplified procedure for small claims is available; (iii) whether pretrial attachment of defendant's movable assets is available; (iv) whether new cases are assigned randomly and through an automated system to judges; and (v) whether a woman’s testimony in court carries the same evidentiary weight as that of a man's. The index is computed based on the methodology in the DB17-20 studies.